Jazz Pharmaceuticals JAZZ Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Jazz Pharmaceuticals’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's earnings yield?
- Jazz Pharmaceuticals (JAZZ) reported earnings yield of -4.6% in Q3 2025.
- How has Jazz Pharmaceuticals's earnings yield changed year-over-year?
- Jazz Pharmaceuticals's earnings yield decreased by 169.7% year-over-year, from 6.6% to -4.6%.
- What is the long-term trend for Jazz Pharmaceuticals's earnings yield?
- Over 4 years (2020 to 2024), Jazz Pharmaceuticals's earnings yield has grown at a 33.7% compound annual growth rate (CAGR), from 2.4% to 7.5%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.